June 22, 2026 · Form 4 insider transaction
Drew Janice Suzann bought 16,161 shares of Evommune, Inc. at $2.99 per share, a transaction worth $48.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The transactions were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2026.